Tbpl2 anticorps (N-Term)

N° du produit ABIN656105

L’anticorps Lapin Polyclonal anti-Tbpl2 a été validé pour WB, IF et IHC (p). Il convient pour détecter Tbpl2 dans des échantillons de Humain.

Aperçu rapide pour Tbpl2 anticorps (N-Term) (ABIN656105)

Antigène: Tbpl2 (TATA Box Binding Protein Like 2 (Tbpl2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Tbpl2 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: RB32201

Détail du produit anti-Tbpl2 anticorps

Épitope: AA 12-39, N-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This TBPL2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 12-39 amino acids from the N-terminal region of human TBPL2.

Isotype: Ig Fraction

Information d'application

Indications d'application: IF: 1:10~50. WB: 1:1000. IHC-P: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Date de péremption: 6 months

Détails sur Tbpl2

Antigène: Tbpl2 (TATA Box Binding Protein Like 2 (Tbpl2))

Autre désignation: TBPL2

Sujet: TBPL2 is a transcription factor required in complex with TAF3 for the differentiation of myoblasts into myocytes. The complex replaces TFIID at specific promoters at an early stage in the differentiation process (By similarity).

Poids moléculaire: 41524

ID gène: 387332

NCBI Accession: NP_950248

UniProt: Q6SJ96

Pathways: Protein targeting to Nucleus, Platelet-derived growth Factor Receptor Signaling